-
Published10/12/2024
-
Deadline14/01/2025
-
Opening of tenders15/01/2025
-
Awarded25/04/2025
-
Today08/08/2026
Utilities
- indicates text translated automatically in your browsing language
Supply of DERIVED BLOOD MEDICAMENTS: NORMAL HUMAN IMMUNOGLOBULINE
Estimated excl. tax for the total duration of the contract: 8.0E7 Euro(s) H.T. The thresholds are expressed in quantity in the consultation documents. Consultation launched by a group of orders. The framework agreement will be implemented by issuing order forms. Each lot will be awarded separately. The services are paid for by unit prices. The estimated amounts are indicative and include all renewal periods. Supply of DERIVED BLOOD MEDICAMENTS: NORMAL HUMAN IMMUNOGLOBULINE
https://www.marches-publics.info/mpiaws/index.cfm?fuseaction=demat.termes&IDM=1570492
https://www.marches-publics.info/mpiaws/index.cfm?fuseaction=demat.termes&IDM=1570492
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.